Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An announcement from Afya ( (AFYA) ) is now available.
Afya Limited, the Brazilian medical education and medical practice solutions group, reported another year of strong performance for 2025, with revenue rising 11.9% to R$3.70 billion and adjusted EBITDA up 15.4% to R$1.68 billion, lifting the margin to 45.4%. Net income grew 18.4% to R$768.4 million, free cash flow hit a record R$1.06 billion, and the company closed the year with about 301,000 users in its ecosystem.
For the fourth quarter of 2025, Afya delivered 7.5% year-on-year revenue growth to R$913.0 million and a 13.7% rise in net income to R$175.4 million, while maintaining robust profitability despite a slight margin compression. Management highlighted that 2025 marked the seventh consecutive period of meeting or exceeding guidance, supported by strong growth in medical undergraduate programs, expanding continuing education and practice solutions, a new share buyback authorization of up to 4 million Class A shares, a declared 2025 dividend of R$307.4 million on March 12, 2026, and an October 2025 R$1.5 billion commercial notes issuance to fund its next growth phase.
The most recent analyst rating on (AFYA) stock is a Hold with a $17.00 price target. To see the full list of analyst forecasts on Afya stock, see the AFYA Stock Forecast page.
Spark’s Take on AFYA Stock
According to Spark, TipRanks’ AI Analyst, AFYA is a Outperform.
Afya’s strong financial performance and positive earnings call are the most significant factors contributing to its score. The company’s robust revenue growth, profitability, and strategic achievements in the earnings call highlight its potential for future success. Technical analysis indicates some bearish momentum, but valuation metrics suggest the stock is reasonably priced.
To see Spark’s full report on AFYA stock, click here.
More about Afya
Afya Limited is a leading Brazilian medical education group and medical practice solutions provider, offering undergraduate medical degrees, continuing education programs, and digital tools for physicians. The company focuses on serving doctors across all stages of their careers in Brazil’s healthcare ecosystem, operating medical school seats nationwide and a growing digital and services-based platform for practitioners.
Average Trading Volume: 112,730
Technical Sentiment Signal: Sell
Current Market Cap: $1.26B
See more insights into AFYA stock on TipRanks’ Stock Analysis page.